Active Biotech enters into global patent license agreement w

Lund, February 9, 2022 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents

Related Keywords

Sweden , Netherlands , Stockholm , Hans Kolam , Rebekka Schneider , Rebekka Schneiders , Erasmus Universiteit Medisch , Loncode Institute , Nasdaq , Erasmus Universiteit Medisch Centrum , Active Biotech , Cell Stem , Active , Biotech , Centers , Lobal , Patent , License , Agreement , Fancode , Institute , Asquinimod , Myelofibrosis ,